Literature DB >> 17410462

The beneficial effect of N-acetylcysteine and ciprofloxacin therapy on the outcome of ischemic fulminant hepatic failure.

Nimer Assy1, Hana Gefen, Sorina Schlesinger, Osamah Hussein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17410462     DOI： 10.1007/s10620-006-9594-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  31 in total

1.  Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine.

Authors:  P M Harrison; R Keays; G P Bray; G J Alexander; R Williams
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

Review 2.  Fulminant hepatic failure.

Authors:  A Mas; J Rodés
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

3.  The beneficial effects of ciprofloxacin on survival and hepatic regenerative activity in a rat model of fulminant hepatic failure.

Authors:  K D Kaita; N Assy; T Gauthier; M Zhang; A F Meyers; G Y Minuk
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

4.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Authors:  M Tepel; M van der Giet; C Schwarzfeld; U Laufer; D Liermann; W Zidek
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

5.  Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

Authors:  J Niebauer; H D Volk; M Kemp; M Dominguez; R R Schumann; M Rauchhaus; P A Poole-Wilson; A J Coats; S D Anker
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

6.  Cardiogenic hepatorenal syndrome.

Authors:  J E Naschitz; D Yeshurun; J Shahar
Journal:  Angiology       Date:  1990-11       Impact factor: 3.619

7.  Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study.

Authors:  S Jepsen; P Herlevsen; P Knudsen; M I Bud; N O Klausen
Journal:  Crit Care Med       Date:  1992-07       Impact factor: 7.598

8.  N-acetyl-L-cysteine for preventing lung reperfusion injury after liver ischemia-reperfusion: a possible dual protective mechanism in a dose-response study.

Authors:  A A Weinbroum; V Rudick; R Ben-Abraham; E Karchevski
Journal:  Transplantation       Date:  2000-03-15       Impact factor: 4.939

Review 9.  N-acetylcysteine in experimental and clinical acute lung injury.

Authors:  G R Bernard
Journal:  Am J Med       Date:  1991-09-30       Impact factor: 4.965

10.  Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function.

Authors:  G R Bernard; W D Lucht; M E Niedermeyer; J R Snapper; M L Ogletree; K L Brigham
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.